Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NIRAPARIB Cause Wrong technique in product usage process? 27 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Wrong technique in product usage process have been filed in association with NIRAPARIB (ZEJULA). This represents 0.1% of all adverse event reports for NIRAPARIB.

27
Reports of Wrong technique in product usage process with NIRAPARIB
0.1%
of all NIRAPARIB reports
3
Deaths
5
Hospitalizations

How Dangerous Is Wrong technique in product usage process From NIRAPARIB?

Of the 27 reports, 3 (11.1%) resulted in death, 5 (18.5%) required hospitalization.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NIRAPARIB. However, 27 reports have been filed with the FAERS database.

What Other Side Effects Does NIRAPARIB Cause?

Nausea (5,794) Fatigue (5,240) Constipation (4,128) Platelet count decreased (4,102) Insomnia (2,861) Blood pressure increased (2,464) Headache (2,383) Off label use (2,213) Vomiting (2,029) Carbohydrate antigen 125 increased (1,868)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which NIRAPARIB Alternatives Have Lower Wrong technique in product usage process Risk?

NIRAPARIB vs NIRMATRELVIR\RITONAVIR NIRAPARIB vs NIROGACESTAT NIRAPARIB vs NIROGACESTAT HYDROBROMIDE NIRAPARIB vs NIRSEVIMAB NIRAPARIB vs NIRSEVIMAB-ALIP

Related Pages

NIRAPARIB Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process NIRAPARIB Demographics